Next Article in Journal
Editorial: Special Issue: “Legionella pneumophila: A Microorganism with a Thousand Faces”
Next Article in Special Issue
Freshwater and Marine Environments in California Are a Reservoir of Carbapenem-Resistant Bacteria
Previous Article in Journal
Ruminant Salivary Microbes: Passenger or Player in the Rumen?
Previous Article in Special Issue
Nanotechnology—A Light of Hope for Combating Antibiotic Resistance
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Supporting Clinical Decisions with Rapid Molecular Diagnostic Pneumonia Panel in Pediatric Intensive Care Unit: Single Center Experience in Turkiye

1
Pediatric Intensive Care Unit, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Türkiye
2
Pediatric Infectious Disease Unit, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Türkiye
3
Department of Microbiology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Türkiye
*
Author to whom correspondence should be addressed.
Microorganisms 2023, 11(10), 2391; https://doi.org/10.3390/microorganisms11102391
Submission received: 4 August 2023 / Revised: 6 September 2023 / Accepted: 8 September 2023 / Published: 25 September 2023
(This article belongs to the Special Issue Antibiotic Resistance: Present Knowledge and Future Challenges)

Abstract

Introduction: Lower respiratory tract infections are the leading cause of morbidity and mortality in children worldwide. It is crucial to promptly conduct diagnostic investigations in order to determine the microbiological cause of pneumonia, since this is necessary to ensure the appropriate delivery of antibiotic therapy to each individual patient. We evaluated the results of a rapid molecular diagnostic pneumonia panel in children with LRTI in a pediatric intensive care unit (PICU). Patients and Methods: Rapid molecular diagnostic pneumonia panel (BioFire®, FilmArray Pneumonia Panel plus; FA-PP) findings (71 results from 46 children) in a tertiary care PICU between 2019 and 2023 were retrospectively reviewed. Results: At least one bacterial pathogen was detected in 57 cases. A total of 77% of children had underlying conditions. A total of 70.4% of children needed invasive mechanical ventilation and 54.4% had ventilator-associated pneumonia. Pseudomonas aeruginosa (50.8%), Acinetobacter calcoaceticus baumannii complex (42%), and Klebsiella pneumoniae (38.6%) were the most common pathogens detected with the FA-PP. Of the 33 cases diagnosed with VAP, more than one pathogen was identified in 65.9% of cases, with the most commonly identified bacteria being K. pneumoniae (43.1%), P. aeruginosa (38.6%), and Acinetobacter calcoaceticus baumannii complex (31.8%). According to the FA-PP results, the same antibiotic therapy was continued in 39.4% of cases, escalated in 54.5%, and de-escalated in 6.1%. Conclusions: The utilization of the FA-PP has some beneficial effects, including more prompt delivery of findings compared to conventional approaches. Additionally, this approach enables the identification of resistance profiles in children diagnosed with pneumonia in the PICU. Consequently, these test results facilitate the organization of antibiotic treatment strategies, including escalation and de-escalation approaches. The detection of resistance patterns was exclusively determined via the implementation of molecular testing, prompting a reevaluation of the isolation technique in accordance with the obtained data.
Keywords: pneumonia; ventilator-associated pneumonia; rapid molecular diagnostic panel; pediatric intensive care unit; antibiotic resistance pneumonia; ventilator-associated pneumonia; rapid molecular diagnostic panel; pediatric intensive care unit; antibiotic resistance

Share and Cite

MDPI and ACS Style

Bozan, G.; Kara, Y.; Kiral, E.; Kizil, M.C.; Kacmaz, E.; Us, T.; Durmaz, G.; Kilic, O.; Dinleyici, E.C. Supporting Clinical Decisions with Rapid Molecular Diagnostic Pneumonia Panel in Pediatric Intensive Care Unit: Single Center Experience in Turkiye. Microorganisms 2023, 11, 2391. https://doi.org/10.3390/microorganisms11102391

AMA Style

Bozan G, Kara Y, Kiral E, Kizil MC, Kacmaz E, Us T, Durmaz G, Kilic O, Dinleyici EC. Supporting Clinical Decisions with Rapid Molecular Diagnostic Pneumonia Panel in Pediatric Intensive Care Unit: Single Center Experience in Turkiye. Microorganisms. 2023; 11(10):2391. https://doi.org/10.3390/microorganisms11102391

Chicago/Turabian Style

Bozan, Gurkan, Yalcin Kara, Eylem Kiral, Mahmut Can Kizil, Ebru Kacmaz, Tercan Us, Gul Durmaz, Omer Kilic, and Ener Cagri Dinleyici. 2023. "Supporting Clinical Decisions with Rapid Molecular Diagnostic Pneumonia Panel in Pediatric Intensive Care Unit: Single Center Experience in Turkiye" Microorganisms 11, no. 10: 2391. https://doi.org/10.3390/microorganisms11102391

APA Style

Bozan, G., Kara, Y., Kiral, E., Kizil, M. C., Kacmaz, E., Us, T., Durmaz, G., Kilic, O., & Dinleyici, E. C. (2023). Supporting Clinical Decisions with Rapid Molecular Diagnostic Pneumonia Panel in Pediatric Intensive Care Unit: Single Center Experience in Turkiye. Microorganisms, 11(10), 2391. https://doi.org/10.3390/microorganisms11102391

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop